Sonoma Pharmaceuticals | DEFA14A: Others
Sonoma Pharmaceuticals | DEFA14A: Others
Sonoma Pharmaceuticals | 10-Q: Q1 2025 Earnings Report
Sonoma Pharmaceuticals | DEFA14A: Others
Sonoma Pharmaceuticals | DEF 14A: Definitive information statements
Sonoma Pharmaceuticals | 8-K: Current report
Sonoma Pharmaceuticals | 424B5: Prospectus
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Trombly Amy Moss
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Thornton Bruce
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Dal Poggetto John
Sonoma Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DVONCH JEROME J
Sonoma Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Sonoma Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Sonoma Pharmaceuticals | 10-K: FY2024 Annual Report
Sonoma Pharmaceuticals | 8-K: Current report
Sonoma Pharmaceuticals | 8-K: Current report
Sonoma Pharmaceuticals | 8-K: Current report
Sonoma Pharmaceuticals | 424B3: Prospectus
Sonoma Pharmaceuticals | 8-K: Current report
Sonoma Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
No Data